Spectrum Vascular

Spectrum Vascular is a medical device company dedicated to vascular access and medication management. The company aims to enhance patient outcomes by providing healthcare providers with high-quality products and exceptional customer service. Its product line features advanced vascular access devices that utilize proprietary technologies. The SV Spectrum™ Technology incorporates catheters impregnated with minocycline and rifampin to offer antimicrobial protection against bloodstream infections. The SV BioFlo Technology employs Endexo®, a surface-modifying macromolecule, to minimize thrombus accumulation, improving catheter performance and patient safety. Spectrum Vascular serves a diverse range of healthcare providers, including hospitals and specialty clinics, focusing on reliable vascular access solutions. The company was acquired by SK Capital Partners in March 2025, underscoring its role as a leader in the vascular access medical device market.

• Employees47